Live data from Hacker News

GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact

fiercebiotech.com

121–130 of 228 posts

Re: GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact

#121
post #97

I see a lot of people making claims about 23andme that haven't used the product, and I just wanted to inform people that in the contract you sign with them, they only share your data if you opt-in to it. They make this all very clear. You can also have them discard your sample and delete your info if you haven't opt-ed in to the research program. Now trusting that 23andme is actually abiding by these rules is a diffe…

Have you EVEN read the title??

They are not sharing this information with private entity aka. opt-in/out. They made partnership research & development agreement in with GSK with invest over $300MM. 23and me is not sharing our data outside their fences BUT this agreement will let them bring GSK into their playground and do all sorts of stuff with your DNA.

Worst case they will just buy the whole 23andMe as a company and once they own it, still your data technically haven't been opted-in/out anywhere, but Glaxo will do whatever they pleased with it :)

Re: GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact

#122
post #43
post #24

I asked 23andMe if there was any way to delete my genetic data from their site after the Equifax hack news. From their response: "23andMe and our third party genotyping laboratory will retain Genetic Information, date of birth, and sex as required for compliance with applicable legal obligations, including the U.S. Federal Clinical Laboratory Improvement Amendments of 1988 (CLIA), California Business and Professional…

I believe there are services that will do whole genome seq for you for under $10k(and I assume won’t keep your data). You could then use Promethease for analysis. I’m unaware of any way you could do self-DNA testing at home unless you wanted to spend $100k+ on equipment, reagents, etc. The Nanopore might be relevant but I haven’t looked into it much.

Full Genomes Corporation[1] will do WGS at 30x for $1295, WGS at 20x for $900, and Long Read WGS (newer technology) for $2900.

For Prime Day, Dante Labs[2] had a sale on a 30x WGS for $349; it's still on sale for $499.

Once you have a WGS you might consider donating it to the Harvard Personal Genomes Project[3], Open Humans[4], or putting it on GitHub[5].

[1]: https://www.fullgenomes.com/whole-genome-sequencing/

[2]: https://us.dantelabs.com/products/whole-genome-sequencing-wg...

[3]: https://pgp.med.harvard.edu/

[4]: https://www.openhumans.org/

[5]: https://github.com/beaugunderson/genome

Re: GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact

#123
post #62

Earlier quoted context omitted.

Using genetic data to find new drugs strikes me as a very good use of this data. Medical data is essential to the process of finding new drugs and treating patients and is highly regulated. I think you're right to be concerned about sharing of genetic data, but conflating facebook / google data sharing practices with medical data sharing is not appropriate If the concern is that 23and me may bring the google / FB app…

Agreed. People underestimate how excruciating it is to collect large sample-sizes of genetic data. The database 23andMe has is so stupidly valuable because 1. the sequencing is already done (and paid for) and 2. They can follow up with surveys electronically. This kind of voluntary ancestry service will probably be the only way we will ever be able to collect the millions of samples needed for powered WGS GWAS analys…

But if people consented to giving their data to an ancestry service, they did not consent to giving their data to a large pharma company. That's morally wrong, no matter what benefit you think can be gleaned from it or how difficult it would be to get otherwise.

Re: GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact

#124

Make no mistake about what is happening here. GSK is buying access to all of the genetic data that 23andMe has. This is why I am wary to use any 23andMe type of service. "The partners plan to use 23andMe’s data to jointly discover drug targets." They will claim all kinds of protections of course, but it is only a matter of time until genetic data starts being resold.

Using genetic data to find new drugs strikes me as a very good use of this data. Medical data is essential to the process of finding new drugs and treating patients and is highly regulated. I think you're right to be concerned about sharing of genetic data, but conflating facebook / google data sharing practices with medical data sharing is not appropriate If the concern is that 23and me may bring the google / FB app…

Using genetic data to find new drugs strikes me as a very good use of this data.

Selling it to anyone who pays the price seems like a bad idea. Which is inevitably what will happen here the next time the company needs to "maximize shareholder value" by "utilizing its assets to their full revenue potential."

Next thing you know, I end up paying higher insurance rates because some distant relative I don't know is predisposed to some disease I've never heard of that is linked to a habit I don't have.

Again, because the insurance company is required to "maximize shareholder value."

Re: GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact

#126
post #97

I see a lot of people making claims about 23andme that haven't used the product, and I just wanted to inform people that in the contract you sign with them, they only share your data if you opt-in to it. They make this all very clear. You can also have them discard your sample and delete your info if you haven't opt-ed in to the research program. Now trusting that 23andme is actually abiding by these rules is a diffe…

Have you EVEN read the title?? They are not sharing this information with private entity aka. opt-in/out. They made partnership research & development agreement in with GSK with invest over $300MM. 23and me is not sharing our data outside their fences BUT this agreement will let them bring GSK into their playground and do all sorts of stuff with your DNA. Worst case they will just buy the whole 23andMe as a company a…

It was made quite clear in the agreement that they cannot use data for research if you opt-out, even inside their own company.

So you're saying any agreement someone has already made with 23andme in regards to their data usage has become null and void because of this investment? And would become if they were bought by another company?

Re: GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact

#127

Earlier quoted context omitted.

Using genetic data to find new drugs strikes me as a very good use of this data. Medical data is essential to the process of finding new drugs and treating patients and is highly regulated. I think you're right to be concerned about sharing of genetic data, but conflating facebook / google data sharing practices with medical data sharing is not appropriate If the concern is that 23and me may bring the google / FB app…

Using genetic data to find new drugs strikes me as a very good use of this data. Selling it to anyone who pays the price seems like a bad idea. Which is inevitably what will happen here the next time the company needs to "maximize shareholder value" by "utilizing its assets to their full revenue potential." Next thing you know, I end up paying higher insurance rates because some distant relative I don't know is predi…

Bingo.

> "maximize shareholder value"

> "utilizing its assets to their full revenue potential."

That's quite literally all that needs to be said here. How people fail to see the downside(s) to a large, multi-national, for-profit, shareholder-value-maximizing corporation, having access to (quite literally) their most sensitive information is simply beyond me. What do people expect GSK to say? "We plan to immediately redistribute this data to generate revenue - oh, and we do plan to do some research as well." GSK is not a charity. They do not run on merit, or "doing good things". They run on making - money. Any revenues from any type of wonder drugs developed via this 23&M partnership will be so far down the line (years, if they even come up with any winners). So in the mean time you can bet that they plan to get their ROI from this _investment_ via some type less than morally reputable activity.

Re: GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact

#128
post #38

Earlier quoted context omitted.

I don't understand these concerns. I have published my data from 23andMe ( https://enki.org/2017/10/17/publishing-my-genome/ ) ( https://github.com/mcculley/genes-genes ). Can you share what you think the bad outcomes would be? What am I missing? Edit: As people bring up the insurance risk, yes I did consider that and mention it in my post. I am personally not concerned about it and think the advantages outweigh the…

In the USA the Genetic Information Nondiscrimination Act of 2008 explicitly prohibits discrimination on the basis of genetic information with respect to health insurance and employment. No one in politically powerful positions has seriously advocated for repealing the law. The insurance companies don't even dislike it because it creates a level playing field; since the market is competitive, even if they were allowed…

the Genetic Information Nondiscrimination Act of 2008 explicitly prohibits discrimination on the basis of genetic information

There are laws against age, race, and other discrimination in employment. But it still happens, and in some industries in widespread.

Greed finds a way. Your point is moot.

Re: GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact

#129

Make no mistake about what is happening here. GSK is buying access to all of the genetic data that 23andMe has. This is why I am wary to use any 23andMe type of service. "The partners plan to use 23andMe’s data to jointly discover drug targets." They will claim all kinds of protections of course, but it is only a matter of time until genetic data starts being resold.

Using genetic data to find new drugs strikes me as a very good use of this data. Medical data is essential to the process of finding new drugs and treating patients and is highly regulated. I think you're right to be concerned about sharing of genetic data, but conflating facebook / google data sharing practices with medical data sharing is not appropriate If the concern is that 23and me may bring the google / FB app…

I'm sure at some point someone will figure out how to better target advertisements based on DNA. In fact I could think of a simple and obvious one - target based on race or sex. More advanced techniques would be to figure out what proclivities you might have, such as being easily addicted to certain substances and behaviors.

Seems dangerous.

Re: GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact

#130
post #109
post #53

Earlier quoted context omitted.

Plenty of other risks. Once you get into the X million+ sample ranges false positives for paternity tests or criminal cases become likely. 10 million tests vs 10 million person database means 1 in 10 trillion false positives happen 10 times.

That's not how it works, the chances of two people matching as identical (on the SNP tested by 23andme) by random is astronomically low - orders of magnitude higher than the total number of humans who've ever lived. Generally at a 7cM overlap you have 50:50 chance whether you're related to that person or not. Anything over say 150cM you're virtually certain to be related (ignoring endogamous populations). At 3,400cM…

You’re assuming a lot with those statistics.

Paternity tests involve random ~50% of your dna. Sperm samples are generally contaminated and thus less clear cut. But, people’s relatives have been used in the past for these tests dropping the bar even further.

However, being related genetically is not enough. Some people have twin siblings they don’t know about pointing out being related is not nessisarily mean you know anything about the other person allowing for false positives even at 3,400cM.

Unlikely sure, but harm comes in many forms. Saying I can’t think of anything is a long way from saying it’s safe.

Post reply on HN